BioLine Rx (NASDAQ: BLRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of BioLine Rx (NASDAQ: BLRX) through any online brokerage.
The latest price target for BioLine Rx (NASDAQ: BLRX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting BLRX to rise to within 12 months (a possible 113.90% upside). 50 analyst firms have reported ratings in the last year.
The stock price for BioLine Rx (NASDAQ: BLRX) is $1.87 last updated August 12, 2022, 8:00 PM UTC.
The next BioLine Rx (BLRX) dividend date is projected to be Thursday, September 1, 2022.
BioLine Rx’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.